Wed, Dec 7, 2022
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index down 0.30% in February, turbulent markets challenge hedge fund traders

Friday, March 18, 2016
Opalesque Industry Update - Hedge funds lost 0.30% in February according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is down 3.25% after two months in 2016.

“The first half of February saw a continuation of January’s downtrends in equities, energy, and high yield,” says Sol Waksman, founder and president of BarclayHedge.

“At mid-month, energy prices began to rise, the Bank of China intervened in currency markets to defend the Yuan, and positive economic news in the US breathed new life into risk assets and equity markets snapped back.”

Overall, 12 of Barclay’s 18 hedge fund indices had losses in February. The Pacific Rim Equities Index was down 2.99%, Healthcare and Biotechnology lost 2.61%, Distressed Securities were down 2.17%, and European Equities gave up 1.32%.

“A little less than half, approximately 42 percent, of the funds tracked by BarclayHedge were able to navigate successfully through February’s turbulent markets,” says Waksman.

On the positive side, the Equity Short Bias Index gained 4.71% in February, Technology was up 0.87%, Merger Arbitrage gained 0.63%, the Event Driven Index was up 0.40%, and Global Macro added 0.50%.

After two months in 2016, all but two hedge fund indices have lost ground. The Healthcare and Biotechnology Index has dropped 11.52%, Pacific Rim Equities Index is down 5.56%, Equity Long Bias has lost 5.47%, Distressed Securities are down 5.30%, and the Emerging Markets Index has lost 4.70%.

The Barclay Fund of Funds Index was down 1.24% in February, and has lost 3.66% year to date.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: Marks delves into what really matters[more]

    B. G., Opalesque Geneva: Howard Marks, co-founder and co-chairman of Oaktree Capital Management, weighs what should and should not matter for investors in his latest memo last week. Among the things t

  2. Legal: British fund manager Jeremy Leach and his firms settle fraud litigation for $11.5m, DOL slams lawsuit seeking to overturn crypto guidance[more]

    British fund manager Jeremy Leach and his firms settle fraud litigation for $11.5m From Offshore Alert: Four days before a trial was due to start in the Cayman Islands, British fund manager Jeremy Leach and eight of his firms settled a fraud complaint by agreeing to pay $11.5 million o

  3. Family offices upbeat on private assets, reduce public assets exposure[more]

    Laxman Pai, Opalesque Asia: Family offices are investing more in private assets and cutting back on investments in public markets, with higher risk-adjusted returns cited as the main driver, said a study. According to the survey findings by German digital private equity firm Moonfare, and the

  4. Opalesque Exclusive: A Swiss managed futures strategy that can offer diversification to any portfolio[more]

    B. G., Opalesque Geneva for New Managers: TARO (R) Diversified is a Swiss algorithmic and systematic investment strategy that offers diversification benefits to almost any professionally managed portfolio through it

  5. Alts manager Medalist Partners acquires a minority stake in Semper Capital to tap opportunities in structured credit[more]

    Laxman Pai, Opalesque Asia: Medalist Partners, which specializes in private credit, has acquired a minority stake in Semper Capital to extend its offerings to the mass market. Medalist currently manages approximately $2.2 billion in assets across strategies in asset-based private credit, struc